300 Companies, One Exhibition: What Made Visitors Stop at Dake Medical
In September, Hall 1 of the Shenzhen Convention and Exhibition Center opened its doors: more than 300 companies poured into a 30,000-square-meter venue.

The 2026 Shenzhen International High-Performance Medical Device Exhibition and Innovative Pharmaceutical Exhibition
From September 21 to 23, the 2026 Shenzhen International High-Performance Medical Device Exhibition and Innovative Pharmaceutical Exhibition was held here. For three days, our booth number was 01C18.
On the day we packed up, watching the reagent kits go into their boxes one by one, I suddenly felt like writing something down.
This exhibition was bigger than we expected
First, the exhibition itself.
This year's theme was “New Quality Pharmaceuticals and Devices, A New Chapter of Innovation”, hosted by the Shenzhen Medical Device Industry Association and the National Innovation Center for High-Performance Medical Devices. The exhibition covered 30,000 square meters, with more than 300 companies from the entire industry chain exhibiting and nearly 20 professional events held alongside it, covering the full chain from technology innovation and clinical research to commercialization and industrial implementation.
Two “firsts” are worth mentioning. First, the event joined hands with the 5th Hong Kong International Biotechnology Forum and Exhibition (BIOHK2026), creating a new model of “one exhibition, two cities”. Second, an APEC Economies Exchange Zone was set up for the first time, putting Shenzhen's pharmaceutical and medical device “going global” achievements on display.
We were part of the Guangming District pavilion. This time Guangming District organized 57 outstanding companies to exhibit together, covering medical imaging, in vitro diagnostics, brain science, biomedicine and other fields. In vitro diagnostics is not the most eye-catching category, but it is one that cannot be overlooked.
What we brought were instruments and reagents we built ourselves

Dake Medical booth: platform analyzers and matching reagents on display together
Dake Medical is a high-tech enterprise specializing in the research, development, production, sales and technical service of in vitro diagnostic instruments and reagents.
Our main business currently covers chemiluminescence immunoassay and HPLC-based HbA1c testing, with instruments and reagents developed and produced in an integrated way and launched to market together.
The company now holds 4 invention patents, 2 utility model patents, 1 design patent and 9 software copyrights, and has been recognized as a “Technology-Based SME” and a “National High-Tech Enterprise”.
What we brought to Booth 01C18 were platform models such as chemiluminescence immunoassay analyzers and HbA1c analyzers, along with matching reagent kits and quality controls. Our product line serves customers with different sample volumes; 53 immunoassay reagents have been developed, covering routine items such as thyroid function, cardiac markers and inflammation, as well as specialty assays such as vitamins, ST2 and Lp-PLA2.
There are also chromatography columns developed and produced in-house: the company has built its own organic synthesis team and developed high-performance strongly acidic cation exchange resin packing, which we pack into columns ourselves under high pressure. Several companies have already established partnerships with Dake in packing materials or chromatography columns.
Our booth was not large, but every instrument and every reagent kit reflects the Dake team's commitment to putting customers first.
For three days, there was never a quiet moment in front of 01C18

Explaining products to customers: from testing principles to the assay menu
On the first morning, when the crowd came in, we were actually a little nervous.
Visitors included laboratory staff from hospitals, who opened with “what CV can you achieve for this assay?”; distributors, who sat down and asked about installation lead time and service coverage; and peers, who stood in front of the booth reading our brochure from cover to cover before looking up and asking, “Do you make this production line yourselves?”

Introducing our instrument and reagent product lines to visitors

The Dake Medical team at the booth
Over three days we told the same story dozens of times: how chemiluminescence immunoassay works, the logic behind HbA1c testing, and why every reagent is validated on our own instruments before it is shipped.
It was tiring, but worth it. Every explanation removed one more question mark from a visitor's face.
Written after the booth was taken down
Three days passed quickly. When we packed up, the sound of dismantling trusses filled the halls.
But some things remain: a few WeChat contacts added on the spot, several sample requests scheduled right after the show, and an increasingly clear direction — on the in vitro diagnostics track, what ultimately matters is not who shouts loudest, but whose instruments are more stable, reagents more accurate and delivery more reliable.
Dake Medical will keep walking this road steadily, and we are glad to walk it together with our peers.
— End —

